nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—CYP2D6—Niacin—atherosclerosis	0.0726	0.169	CbGbCtD
Galantamine—CYP2D6—Simvastatin—atherosclerosis	0.0574	0.134	CbGbCtD
Galantamine—CYP2D6—Pravastatin—atherosclerosis	0.0562	0.131	CbGbCtD
Galantamine—CYP2D6—Lovastatin—atherosclerosis	0.0562	0.131	CbGbCtD
Galantamine—CYP3A4—Ezetimibe—atherosclerosis	0.0393	0.0916	CbGbCtD
Galantamine—CYP3A4—Rosuvastatin—atherosclerosis	0.0393	0.0916	CbGbCtD
Galantamine—CYP3A4—Simvastatin—atherosclerosis	0.0365	0.0851	CbGbCtD
Galantamine—CYP3A4—Pravastatin—atherosclerosis	0.0357	0.0833	CbGbCtD
Galantamine—CYP3A4—Lovastatin—atherosclerosis	0.0357	0.0833	CbGbCtD
Galantamine—Depression—Pravastatin—atherosclerosis	0.00131	0.00273	CcSEcCtD
Galantamine—Hepatitis—Simvastatin—atherosclerosis	0.00131	0.00272	CcSEcCtD
Galantamine—Flushing—Lovastatin—atherosclerosis	0.0013	0.0027	CcSEcCtD
Galantamine—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00129	0.00268	CcSEcCtD
Galantamine—Urinary tract infection—Pravastatin—atherosclerosis	0.00128	0.00266	CcSEcCtD
Galantamine—Flushing—Ezetimibe—atherosclerosis	0.00127	0.00265	CcSEcCtD
Galantamine—Cough—Rosuvastatin—atherosclerosis	0.00125	0.0026	CcSEcCtD
Galantamine—Angiopathy—Ezetimibe—atherosclerosis	0.00125	0.00259	CcSEcCtD
Galantamine—Immune system disorder—Ezetimibe—atherosclerosis	0.00124	0.00257	CcSEcCtD
Galantamine—Myalgia—Rosuvastatin—atherosclerosis	0.00122	0.00254	CcSEcCtD
Galantamine—Arthralgia—Rosuvastatin—atherosclerosis	0.00122	0.00254	CcSEcCtD
Galantamine—Flushing—Simvastatin—atherosclerosis	0.00121	0.00252	CcSEcCtD
Galantamine—Haemoglobin—Niacin—atherosclerosis	0.00121	0.00251	CcSEcCtD
Galantamine—Rhinitis—Niacin—atherosclerosis	0.0012	0.0025	CcSEcCtD
Galantamine—Mental disorder—Ezetimibe—atherosclerosis	0.0012	0.0025	CcSEcCtD
Galantamine—Haemorrhage—Niacin—atherosclerosis	0.0012	0.0025	CcSEcCtD
Galantamine—Hepatitis—Niacin—atherosclerosis	0.0012	0.0025	CcSEcCtD
Galantamine—Flatulence—Lovastatin—atherosclerosis	0.0012	0.00249	CcSEcCtD
Galantamine—Malnutrition—Ezetimibe—atherosclerosis	0.00119	0.00248	CcSEcCtD
Galantamine—Dysgeusia—Lovastatin—atherosclerosis	0.00119	0.00248	CcSEcCtD
Galantamine—Rhinitis—Pravastatin—atherosclerosis	0.00119	0.00246	CcSEcCtD
Galantamine—Oedema peripheral—Niacin—atherosclerosis	0.00118	0.00246	CcSEcCtD
Galantamine—Hepatitis—Pravastatin—atherosclerosis	0.00118	0.00246	CcSEcCtD
Galantamine—Confusional state—Rosuvastatin—atherosclerosis	0.00118	0.00246	CcSEcCtD
Galantamine—Back pain—Lovastatin—atherosclerosis	0.00118	0.00245	CcSEcCtD
Galantamine—Flatulence—Ezetimibe—atherosclerosis	0.00118	0.00245	CcSEcCtD
Galantamine—Muscle spasms—Lovastatin—atherosclerosis	0.00117	0.00243	CcSEcCtD
Galantamine—Visual impairment—Niacin—atherosclerosis	0.00116	0.00241	CcSEcCtD
Galantamine—Back pain—Ezetimibe—atherosclerosis	0.00116	0.0024	CcSEcCtD
Galantamine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00115	0.00239	CcSEcCtD
Galantamine—Muscle spasms—Ezetimibe—atherosclerosis	0.00115	0.00239	CcSEcCtD
Galantamine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00115	0.00239	CcSEcCtD
Galantamine—Vision blurred—Lovastatin—atherosclerosis	0.00115	0.00238	CcSEcCtD
Galantamine—Mental disorder—Simvastatin—atherosclerosis	0.00115	0.00238	CcSEcCtD
Galantamine—Tremor—Lovastatin—atherosclerosis	0.00114	0.00237	CcSEcCtD
Galantamine—Visual impairment—Pravastatin—atherosclerosis	0.00114	0.00237	CcSEcCtD
Galantamine—Ill-defined disorder—Lovastatin—atherosclerosis	0.00113	0.00235	CcSEcCtD
Galantamine—Eye disorder—Niacin—atherosclerosis	0.00112	0.00233	CcSEcCtD
Galantamine—Flatulence—Simvastatin—atherosclerosis	0.00112	0.00233	CcSEcCtD
Galantamine—Tinnitus—Niacin—atherosclerosis	0.00112	0.00233	CcSEcCtD
Galantamine—Dysgeusia—Simvastatin—atherosclerosis	0.00112	0.00232	CcSEcCtD
Galantamine—Flushing—Niacin—atherosclerosis	0.00112	0.00232	CcSEcCtD
Galantamine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00111	0.0023	CcSEcCtD
Galantamine—Anaemia—Ezetimibe—atherosclerosis	0.0011	0.00229	CcSEcCtD
Galantamine—Tinnitus—Pravastatin—atherosclerosis	0.0011	0.00229	CcSEcCtD
Galantamine—Malaise—Lovastatin—atherosclerosis	0.0011	0.00228	CcSEcCtD
Galantamine—Flushing—Pravastatin—atherosclerosis	0.0011	0.00228	CcSEcCtD
Galantamine—Cardiac disorder—Pravastatin—atherosclerosis	0.0011	0.00228	CcSEcCtD
Galantamine—Muscle spasms—Simvastatin—atherosclerosis	0.0011	0.00228	CcSEcCtD
Galantamine—Vertigo—Lovastatin—atherosclerosis	0.00109	0.00227	CcSEcCtD
Galantamine—Angiopathy—Niacin—atherosclerosis	0.00109	0.00226	CcSEcCtD
Galantamine—Malaise—Ezetimibe—atherosclerosis	0.00108	0.00224	CcSEcCtD
Galantamine—Vision blurred—Simvastatin—atherosclerosis	0.00107	0.00223	CcSEcCtD
Galantamine—Arrhythmia—Niacin—atherosclerosis	0.00107	0.00223	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00107	0.00222	CcSEcCtD
Galantamine—Tremor—Simvastatin—atherosclerosis	0.00107	0.00222	CcSEcCtD
Galantamine—Insomnia—Rosuvastatin—atherosclerosis	0.00106	0.0022	CcSEcCtD
Galantamine—Ill-defined disorder—Simvastatin—atherosclerosis	0.00106	0.0022	CcSEcCtD
Galantamine—Arrhythmia—Pravastatin—atherosclerosis	0.00106	0.0022	CcSEcCtD
Galantamine—Palpitations—Ezetimibe—atherosclerosis	0.00106	0.00219	CcSEcCtD
Galantamine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00105	0.00219	CcSEcCtD
Galantamine—Anaemia—Simvastatin—atherosclerosis	0.00105	0.00219	CcSEcCtD
Galantamine—Malnutrition—Niacin—atherosclerosis	0.00105	0.00217	CcSEcCtD
Galantamine—Cough—Ezetimibe—atherosclerosis	0.00104	0.00217	CcSEcCtD
Galantamine—Arthralgia—Lovastatin—atherosclerosis	0.00104	0.00215	CcSEcCtD
Galantamine—Chest pain—Lovastatin—atherosclerosis	0.00104	0.00215	CcSEcCtD
Galantamine—Myalgia—Lovastatin—atherosclerosis	0.00104	0.00215	CcSEcCtD
Galantamine—Anxiety—Lovastatin—atherosclerosis	0.00103	0.00215	CcSEcCtD
Galantamine—Dyspepsia—Rosuvastatin—atherosclerosis	0.00103	0.00214	CcSEcCtD
Galantamine—Hypertension—Ezetimibe—atherosclerosis	0.00103	0.00214	CcSEcCtD
Galantamine—Flatulence—Niacin—atherosclerosis	0.00103	0.00214	CcSEcCtD
Galantamine—Malaise—Simvastatin—atherosclerosis	0.00103	0.00213	CcSEcCtD
Galantamine—Tension—Niacin—atherosclerosis	0.00103	0.00213	CcSEcCtD
Galantamine—Discomfort—Lovastatin—atherosclerosis	0.00102	0.00213	CcSEcCtD
Galantamine—Vertigo—Simvastatin—atherosclerosis	0.00102	0.00213	CcSEcCtD
Galantamine—Myalgia—Ezetimibe—atherosclerosis	0.00102	0.00211	CcSEcCtD
Galantamine—Chest pain—Ezetimibe—atherosclerosis	0.00102	0.00211	CcSEcCtD
Galantamine—Arthralgia—Ezetimibe—atherosclerosis	0.00102	0.00211	CcSEcCtD
Galantamine—Nervousness—Niacin—atherosclerosis	0.00102	0.00211	CcSEcCtD
Galantamine—Flatulence—Pravastatin—atherosclerosis	0.00101	0.00211	CcSEcCtD
Galantamine—Dry mouth—Lovastatin—atherosclerosis	0.00101	0.00211	CcSEcCtD
Galantamine—Tension—Pravastatin—atherosclerosis	0.00101	0.0021	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00101	0.0021	CcSEcCtD
Galantamine—Dysgeusia—Pravastatin—atherosclerosis	0.00101	0.0021	CcSEcCtD
Galantamine—Muscle spasms—Niacin—atherosclerosis	0.00101	0.00209	CcSEcCtD
Galantamine—Discomfort—Ezetimibe—atherosclerosis	0.001	0.00209	CcSEcCtD
Galantamine—Constipation—Rosuvastatin—atherosclerosis	0.001	0.00208	CcSEcCtD
Galantamine—Confusional state—Lovastatin—atherosclerosis	0.001	0.00208	CcSEcCtD
Galantamine—Nervousness—Pravastatin—atherosclerosis	0.001	0.00208	CcSEcCtD
Galantamine—Dry mouth—Ezetimibe—atherosclerosis	0.000995	0.00207	CcSEcCtD
Galantamine—Muscle spasms—Pravastatin—atherosclerosis	0.00099	0.00206	CcSEcCtD
Galantamine—Vision blurred—Niacin—atherosclerosis	0.000986	0.00205	CcSEcCtD
Galantamine—Confusional state—Ezetimibe—atherosclerosis	0.000983	0.00204	CcSEcCtD
Galantamine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000973	0.00202	CcSEcCtD
Galantamine—Vision blurred—Pravastatin—atherosclerosis	0.000971	0.00202	CcSEcCtD
Galantamine—Chest pain—Simvastatin—atherosclerosis	0.00097	0.00201	CcSEcCtD
Galantamine—Myalgia—Simvastatin—atherosclerosis	0.00097	0.00201	CcSEcCtD
Galantamine—Arthralgia—Simvastatin—atherosclerosis	0.00097	0.00201	CcSEcCtD
Galantamine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000967	0.00201	CcSEcCtD
Galantamine—Anxiety—Simvastatin—atherosclerosis	0.000967	0.00201	CcSEcCtD
Galantamine—Tremor—Pravastatin—atherosclerosis	0.000965	0.002	CcSEcCtD
Galantamine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000959	0.00199	CcSEcCtD
Galantamine—Discomfort—Simvastatin—atherosclerosis	0.000958	0.00199	CcSEcCtD
Galantamine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000956	0.00199	CcSEcCtD
Galantamine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000956	0.00198	CcSEcCtD
Galantamine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000955	0.00198	CcSEcCtD
Galantamine—Anaemia—Pravastatin—atherosclerosis	0.000952	0.00198	CcSEcCtD
Galantamine—Anorexia—Lovastatin—atherosclerosis	0.000948	0.00197	CcSEcCtD
Galantamine—Skin disorder—Ezetimibe—atherosclerosis	0.000947	0.00197	CcSEcCtD
Galantamine—Vertigo—Niacin—atherosclerosis	0.00094	0.00195	CcSEcCtD
Galantamine—Syncope—Niacin—atherosclerosis	0.000938	0.00195	CcSEcCtD
Galantamine—Confusional state—Simvastatin—atherosclerosis	0.000938	0.00195	CcSEcCtD
Galantamine—Malaise—Pravastatin—atherosclerosis	0.000929	0.00193	CcSEcCtD
Galantamine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000927	0.00193	CcSEcCtD
Galantamine—Vertigo—Pravastatin—atherosclerosis	0.000925	0.00192	CcSEcCtD
Galantamine—Palpitations—Niacin—atherosclerosis	0.000924	0.00192	CcSEcCtD
Galantamine—Loss of consciousness—Niacin—atherosclerosis	0.000919	0.00191	CcSEcCtD
Galantamine—Cough—Niacin—atherosclerosis	0.000913	0.0019	CcSEcCtD
Galantamine—Thrombocytopenia—Simvastatin—atherosclerosis	0.00091	0.00189	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000906	0.00188	CcSEcCtD
Galantamine—Insomnia—Lovastatin—atherosclerosis	0.000899	0.00187	CcSEcCtD
Galantamine—Cough—Pravastatin—atherosclerosis	0.000899	0.00187	CcSEcCtD
Galantamine—Paraesthesia—Lovastatin—atherosclerosis	0.000893	0.00185	CcSEcCtD
Galantamine—Myalgia—Niacin—atherosclerosis	0.000891	0.00185	CcSEcCtD
Galantamine—Arthralgia—Niacin—atherosclerosis	0.000891	0.00185	CcSEcCtD
Galantamine—Hypertension—Pravastatin—atherosclerosis	0.000889	0.00185	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000888	0.00185	CcSEcCtD
Galantamine—Anorexia—Simvastatin—atherosclerosis	0.000886	0.00184	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000884	0.00184	CcSEcCtD
Galantamine—Insomnia—Ezetimibe—atherosclerosis	0.000882	0.00183	CcSEcCtD
Galantamine—Arthralgia—Pravastatin—atherosclerosis	0.000877	0.00182	CcSEcCtD
Galantamine—Myalgia—Pravastatin—atherosclerosis	0.000877	0.00182	CcSEcCtD
Galantamine—Chest pain—Pravastatin—atherosclerosis	0.000877	0.00182	CcSEcCtD
Galantamine—Paraesthesia—Ezetimibe—atherosclerosis	0.000875	0.00182	CcSEcCtD
Galantamine—Dyspepsia—Lovastatin—atherosclerosis	0.000875	0.00182	CcSEcCtD
Galantamine—Anxiety—Pravastatin—atherosclerosis	0.000874	0.00182	CcSEcCtD
Galantamine—Dry mouth—Niacin—atherosclerosis	0.000871	0.00181	CcSEcCtD
Galantamine—Discomfort—Pravastatin—atherosclerosis	0.000866	0.0018	CcSEcCtD
Galantamine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000864	0.0018	CcSEcCtD
Galantamine—Decreased appetite—Lovastatin—atherosclerosis	0.000864	0.00179	CcSEcCtD
Galantamine—Dyspepsia—Ezetimibe—atherosclerosis	0.000858	0.00178	CcSEcCtD
Galantamine—Fatigue—Lovastatin—atherosclerosis	0.000857	0.00178	CcSEcCtD
Galantamine—Constipation—Lovastatin—atherosclerosis	0.00085	0.00177	CcSEcCtD
Galantamine—Confusional state—Pravastatin—atherosclerosis	0.000848	0.00176	CcSEcCtD
Galantamine—Decreased appetite—Ezetimibe—atherosclerosis	0.000848	0.00176	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000847	0.00176	CcSEcCtD
Galantamine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000842	0.00175	CcSEcCtD
Galantamine—Asthenia—Rosuvastatin—atherosclerosis	0.000842	0.00175	CcSEcCtD
Galantamine—Insomnia—Simvastatin—atherosclerosis	0.000841	0.00175	CcSEcCtD
Galantamine—Fatigue—Ezetimibe—atherosclerosis	0.000841	0.00175	CcSEcCtD
Galantamine—Shock—Niacin—atherosclerosis	0.00084	0.00174	CcSEcCtD
Galantamine—Paraesthesia—Simvastatin—atherosclerosis	0.000835	0.00173	CcSEcCtD
Galantamine—Constipation—Ezetimibe—atherosclerosis	0.000834	0.00173	CcSEcCtD
Galantamine—Tachycardia—Niacin—atherosclerosis	0.000833	0.00173	CcSEcCtD
Galantamine—Skin disorder—Niacin—atherosclerosis	0.000829	0.00172	CcSEcCtD
Galantamine—Hyperhidrosis—Niacin—atherosclerosis	0.000825	0.00171	CcSEcCtD
Galantamine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000823	0.00171	CcSEcCtD
Galantamine—Feeling abnormal—Lovastatin—atherosclerosis	0.000819	0.0017	CcSEcCtD
Galantamine—Dyspepsia—Simvastatin—atherosclerosis	0.000818	0.0017	CcSEcCtD
Galantamine—Anorexia—Niacin—atherosclerosis	0.000814	0.00169	CcSEcCtD
Galantamine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000813	0.00169	CcSEcCtD
Galantamine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000813	0.00169	CcSEcCtD
Galantamine—Decreased appetite—Simvastatin—atherosclerosis	0.000808	0.00168	CcSEcCtD
Galantamine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000803	0.00167	CcSEcCtD
Galantamine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000803	0.00167	CcSEcCtD
Galantamine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000803	0.00167	CcSEcCtD
Galantamine—Fatigue—Simvastatin—atherosclerosis	0.000802	0.00167	CcSEcCtD
Galantamine—Anorexia—Pravastatin—atherosclerosis	0.000801	0.00166	CcSEcCtD
Galantamine—Hypotension—Niacin—atherosclerosis	0.000798	0.00166	CcSEcCtD
Galantamine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000797	0.00166	CcSEcCtD
Galantamine—Constipation—Simvastatin—atherosclerosis	0.000795	0.00165	CcSEcCtD
Galantamine—Abdominal pain—Lovastatin—atherosclerosis	0.000786	0.00163	CcSEcCtD
Galantamine—Body temperature increased—Lovastatin—atherosclerosis	0.000786	0.00163	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000778	0.00162	CcSEcCtD
Galantamine—Dizziness—Rosuvastatin—atherosclerosis	0.000776	0.00161	CcSEcCtD
Galantamine—Insomnia—Niacin—atherosclerosis	0.000772	0.0016	CcSEcCtD
Galantamine—Body temperature increased—Ezetimibe—atherosclerosis	0.000771	0.0016	CcSEcCtD
Galantamine—Abdominal pain—Ezetimibe—atherosclerosis	0.000771	0.0016	CcSEcCtD
Galantamine—Paraesthesia—Niacin—atherosclerosis	0.000767	0.00159	CcSEcCtD
Galantamine—Feeling abnormal—Simvastatin—atherosclerosis	0.000766	0.00159	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000766	0.00159	CcSEcCtD
Galantamine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00076	0.00158	CcSEcCtD
Galantamine—Insomnia—Pravastatin—atherosclerosis	0.00076	0.00158	CcSEcCtD
Galantamine—Somnolence—Niacin—atherosclerosis	0.000759	0.00158	CcSEcCtD
Galantamine—Paraesthesia—Pravastatin—atherosclerosis	0.000755	0.00157	CcSEcCtD
Galantamine—Dyspepsia—Niacin—atherosclerosis	0.000752	0.00156	CcSEcCtD
Galantamine—Decreased appetite—Niacin—atherosclerosis	0.000742	0.00154	CcSEcCtD
Galantamine—Dyspepsia—Pravastatin—atherosclerosis	0.00074	0.00154	CcSEcCtD
Galantamine—Rash—Rosuvastatin—atherosclerosis	0.00074	0.00154	CcSEcCtD
Galantamine—Dermatitis—Rosuvastatin—atherosclerosis	0.000739	0.00153	CcSEcCtD
Galantamine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000737	0.00153	CcSEcCtD
Galantamine—Abdominal pain—Simvastatin—atherosclerosis	0.000735	0.00153	CcSEcCtD
Galantamine—Body temperature increased—Simvastatin—atherosclerosis	0.000735	0.00153	CcSEcCtD
Galantamine—Headache—Rosuvastatin—atherosclerosis	0.000735	0.00153	CcSEcCtD
Galantamine—Hypersensitivity—Lovastatin—atherosclerosis	0.000732	0.00152	CcSEcCtD
Galantamine—Decreased appetite—Pravastatin—atherosclerosis	0.000731	0.00152	CcSEcCtD
Galantamine—Fatigue—Pravastatin—atherosclerosis	0.000725	0.00151	CcSEcCtD
Galantamine—Constipation—Pravastatin—atherosclerosis	0.000719	0.00149	CcSEcCtD
Galantamine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000718	0.00149	CcSEcCtD
Galantamine—Asthenia—Lovastatin—atherosclerosis	0.000713	0.00148	CcSEcCtD
Galantamine—Asthenia—Ezetimibe—atherosclerosis	0.0007	0.00145	CcSEcCtD
Galantamine—Gastrointestinal pain—Niacin—atherosclerosis	0.000698	0.00145	CcSEcCtD
Galantamine—Nausea—Rosuvastatin—atherosclerosis	0.000697	0.00145	CcSEcCtD
Galantamine—Feeling abnormal—Pravastatin—atherosclerosis	0.000693	0.00144	CcSEcCtD
Galantamine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000687	0.00143	CcSEcCtD
Galantamine—Hypersensitivity—Simvastatin—atherosclerosis	0.000685	0.00142	CcSEcCtD
Galantamine—Diarrhoea—Lovastatin—atherosclerosis	0.00068	0.00141	CcSEcCtD
Galantamine—Abdominal pain—Niacin—atherosclerosis	0.000675	0.0014	CcSEcCtD
Galantamine—Body temperature increased—Niacin—atherosclerosis	0.000675	0.0014	CcSEcCtD
Galantamine—Asthenia—Simvastatin—atherosclerosis	0.000667	0.00139	CcSEcCtD
Galantamine—Diarrhoea—Ezetimibe—atherosclerosis	0.000667	0.00139	CcSEcCtD
Galantamine—Body temperature increased—Pravastatin—atherosclerosis	0.000665	0.00138	CcSEcCtD
Galantamine—Abdominal pain—Pravastatin—atherosclerosis	0.000665	0.00138	CcSEcCtD
Galantamine—Dizziness—Lovastatin—atherosclerosis	0.000657	0.00137	CcSEcCtD
Galantamine—Dizziness—Ezetimibe—atherosclerosis	0.000645	0.00134	CcSEcCtD
Galantamine—Diarrhoea—Simvastatin—atherosclerosis	0.000636	0.00132	CcSEcCtD
Galantamine—Vomiting—Lovastatin—atherosclerosis	0.000632	0.00131	CcSEcCtD
Galantamine—Hypersensitivity—Niacin—atherosclerosis	0.000629	0.00131	CcSEcCtD
Galantamine—Rash—Lovastatin—atherosclerosis	0.000627	0.0013	CcSEcCtD
Galantamine—Dermatitis—Lovastatin—atherosclerosis	0.000626	0.0013	CcSEcCtD
Galantamine—Headache—Lovastatin—atherosclerosis	0.000623	0.00129	CcSEcCtD
Galantamine—Vomiting—Ezetimibe—atherosclerosis	0.00062	0.00129	CcSEcCtD
Galantamine—Hypersensitivity—Pravastatin—atherosclerosis	0.000619	0.00129	CcSEcCtD
Galantamine—Dizziness—Simvastatin—atherosclerosis	0.000615	0.00128	CcSEcCtD
Galantamine—Rash—Ezetimibe—atherosclerosis	0.000615	0.00128	CcSEcCtD
Galantamine—Dermatitis—Ezetimibe—atherosclerosis	0.000614	0.00128	CcSEcCtD
Galantamine—Asthenia—Niacin—atherosclerosis	0.000613	0.00127	CcSEcCtD
Galantamine—Headache—Ezetimibe—atherosclerosis	0.000611	0.00127	CcSEcCtD
Galantamine—Asthenia—Pravastatin—atherosclerosis	0.000603	0.00125	CcSEcCtD
Galantamine—Vomiting—Simvastatin—atherosclerosis	0.000591	0.00123	CcSEcCtD
Galantamine—Nausea—Lovastatin—atherosclerosis	0.00059	0.00123	CcSEcCtD
Galantamine—Rash—Simvastatin—atherosclerosis	0.000586	0.00122	CcSEcCtD
Galantamine—Dermatitis—Simvastatin—atherosclerosis	0.000586	0.00122	CcSEcCtD
Galantamine—Diarrhoea—Niacin—atherosclerosis	0.000584	0.00121	CcSEcCtD
Galantamine—Headache—Simvastatin—atherosclerosis	0.000582	0.00121	CcSEcCtD
Galantamine—Nausea—Ezetimibe—atherosclerosis	0.000579	0.0012	CcSEcCtD
Galantamine—Diarrhoea—Pravastatin—atherosclerosis	0.000575	0.00119	CcSEcCtD
Galantamine—Dizziness—Niacin—atherosclerosis	0.000565	0.00117	CcSEcCtD
Galantamine—Dizziness—Pravastatin—atherosclerosis	0.000556	0.00115	CcSEcCtD
Galantamine—Nausea—Simvastatin—atherosclerosis	0.000552	0.00115	CcSEcCtD
Galantamine—Vomiting—Niacin—atherosclerosis	0.000543	0.00113	CcSEcCtD
Galantamine—Rash—Niacin—atherosclerosis	0.000538	0.00112	CcSEcCtD
Galantamine—Dermatitis—Niacin—atherosclerosis	0.000538	0.00112	CcSEcCtD
Galantamine—Headache—Niacin—atherosclerosis	0.000535	0.00111	CcSEcCtD
Galantamine—Vomiting—Pravastatin—atherosclerosis	0.000534	0.00111	CcSEcCtD
Galantamine—Rash—Pravastatin—atherosclerosis	0.00053	0.0011	CcSEcCtD
Galantamine—Dermatitis—Pravastatin—atherosclerosis	0.00053	0.0011	CcSEcCtD
Galantamine—Headache—Pravastatin—atherosclerosis	0.000527	0.00109	CcSEcCtD
Galantamine—Nausea—Niacin—atherosclerosis	0.000507	0.00105	CcSEcCtD
Galantamine—Nausea—Pravastatin—atherosclerosis	0.000499	0.00104	CcSEcCtD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	6.94e-05	0.000772	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	6.94e-05	0.000772	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL6—atherosclerosis	6.72e-05	0.000748	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ABCG1—atherosclerosis	6.6e-05	0.000734	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—F7—atherosclerosis	6.56e-05	0.00073	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—GHRL—atherosclerosis	6.55e-05	0.000729	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	6.5e-05	0.000723	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	6.39e-05	0.00071	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—ACE—atherosclerosis	6.35e-05	0.000706	CbGpPWpGaD
Galantamine—ACHE—Metabolism—LCAT—atherosclerosis	6.2e-05	0.00069	CbGpPWpGaD
Galantamine—ACHE—Metabolism—FABP4—atherosclerosis	6.2e-05	0.00069	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	6.19e-05	0.000688	CbGpPWpGaD
Galantamine—ACHE—Metabolism—APOA4—atherosclerosis	6.09e-05	0.000677	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP7A1—atherosclerosis	5.98e-05	0.000665	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—GSTM1—atherosclerosis	5.92e-05	0.000659	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	5.9e-05	0.000656	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ABCG1—atherosclerosis	5.89e-05	0.000655	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—GHRL—atherosclerosis	5.85e-05	0.00065	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—GSTM1—atherosclerosis	5.84e-05	0.00065	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—PLAUR—atherosclerosis	5.7e-05	0.000634	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	5.7e-05	0.000634	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—ACE—atherosclerosis	5.66e-05	0.00063	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	5.58e-05	0.000621	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—PLG—atherosclerosis	5.57e-05	0.00062	CbGpPWpGaD
Galantamine—BCHE—Metabolism—LCAT—atherosclerosis	5.53e-05	0.000616	CbGpPWpGaD
Galantamine—BCHE—Metabolism—FABP4—atherosclerosis	5.53e-05	0.000616	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP27A1—atherosclerosis	5.53e-05	0.000615	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	5.44e-05	0.000605	CbGpPWpGaD
Galantamine—BCHE—Metabolism—APOA4—atherosclerosis	5.43e-05	0.000604	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	5.41e-05	0.000602	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP7A1—atherosclerosis	5.34e-05	0.000594	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	5.31e-05	0.000591	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALOX15—atherosclerosis	5.24e-05	0.000583	CbGpPWpGaD
Galantamine—ACHE—Metabolism—APOA2—atherosclerosis	5.24e-05	0.000583	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALOX5AP—atherosclerosis	5.24e-05	0.000583	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PLA2G2A—atherosclerosis	5.24e-05	0.000583	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ABCG5—atherosclerosis	5.18e-05	0.000576	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	5.17e-05	0.000575	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—PLAUR—atherosclerosis	5.09e-05	0.000566	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	5.09e-05	0.000566	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—IGF2—atherosclerosis	5.07e-05	0.000564	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	5.05e-05	0.000562	CbGpPWpGaD
Galantamine—ACHE—Metabolism—LPA—atherosclerosis	5e-05	0.000556	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—PLG—atherosclerosis	4.97e-05	0.000553	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP27A1—atherosclerosis	4.93e-05	0.000549	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	4.86e-05	0.00054	CbGpPWpGaD
Galantamine—ACHE—Metabolism—BGN—atherosclerosis	4.84e-05	0.000539	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	4.81e-05	0.000535	CbGpPWpGaD
Galantamine—ACHE—Metabolism—APOA5—atherosclerosis	4.79e-05	0.000533	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	4.74e-05	0.000527	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALOX5AP—atherosclerosis	4.68e-05	0.00052	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PLA2G2A—atherosclerosis	4.68e-05	0.00052	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALOX15—atherosclerosis	4.68e-05	0.00052	CbGpPWpGaD
Galantamine—BCHE—Metabolism—APOA2—atherosclerosis	4.68e-05	0.00052	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	4.66e-05	0.000518	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ABCG5—atherosclerosis	4.62e-05	0.000514	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PLA2G1B—atherosclerosis	4.61e-05	0.000513	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	4.61e-05	0.000513	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	4.56e-05	0.000507	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—IGF2—atherosclerosis	4.53e-05	0.000503	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	4.52e-05	0.000503	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	4.51e-05	0.000502	CbGpPWpGaD
Galantamine—BCHE—Metabolism—LPA—atherosclerosis	4.46e-05	0.000496	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALOX5—atherosclerosis	4.46e-05	0.000496	CbGpPWpGaD
Galantamine—BCHE—Metabolism—BGN—atherosclerosis	4.32e-05	0.000481	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	4.29e-05	0.000477	CbGpPWpGaD
Galantamine—BCHE—Metabolism—APOA5—atherosclerosis	4.28e-05	0.000476	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—LDLRAP1—atherosclerosis	4.2e-05	0.000467	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	4.15e-05	0.000462	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.12e-05	0.000458	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PLA2G1B—atherosclerosis	4.12e-05	0.000458	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MMP1—atherosclerosis	4.07e-05	0.000453	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	4.07e-05	0.000453	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	4.03e-05	0.000449	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	4.02e-05	0.000448	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—AGT—atherosclerosis	4.02e-05	0.000448	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NAMPT—atherosclerosis	4e-05	0.000445	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALOX5—atherosclerosis	3.98e-05	0.000442	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.97e-05	0.000442	CbGpPWpGaD
Galantamine—ACHE—Metabolism—LIPC—atherosclerosis	3.97e-05	0.000442	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PLTP—atherosclerosis	3.95e-05	0.000439	CbGpPWpGaD
Galantamine—ACHE—Metabolism—APOC3—atherosclerosis	3.95e-05	0.000439	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—LEP—atherosclerosis	3.94e-05	0.000439	CbGpPWpGaD
Galantamine—ACHE—Metabolism—LDLR—atherosclerosis	3.92e-05	0.000436	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	3.87e-05	0.000431	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CETP—atherosclerosis	3.83e-05	0.000426	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	3.82e-05	0.000425	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	3.76e-05	0.000419	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—F2—atherosclerosis	3.72e-05	0.000414	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.67e-05	0.000409	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SCARB1—atherosclerosis	3.67e-05	0.000408	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MMP1—atherosclerosis	3.63e-05	0.000404	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—AGT—atherosclerosis	3.59e-05	0.000399	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.57e-05	0.000397	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NAMPT—atherosclerosis	3.57e-05	0.000397	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.55e-05	0.000394	CbGpPWpGaD
Galantamine—BCHE—Metabolism—LIPC—atherosclerosis	3.54e-05	0.000394	CbGpPWpGaD
Galantamine—BCHE—Metabolism—APOC3—atherosclerosis	3.52e-05	0.000392	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—LEP—atherosclerosis	3.52e-05	0.000391	CbGpPWpGaD
Galantamine—BCHE—Metabolism—LDLR—atherosclerosis	3.5e-05	0.000389	CbGpPWpGaD
Galantamine—ACHE—Metabolism—HMGCR—atherosclerosis	3.47e-05	0.000386	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—LTA4H—atherosclerosis	3.42e-05	0.000381	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ABCG8—atherosclerosis	3.42e-05	0.000381	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CETP—atherosclerosis	3.42e-05	0.00038	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—INS—atherosclerosis	3.37e-05	0.000375	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—F2—atherosclerosis	3.32e-05	0.000369	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CCL2—atherosclerosis	3.31e-05	0.000369	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SCARB1—atherosclerosis	3.27e-05	0.000364	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—IGF1—atherosclerosis	3.26e-05	0.000362	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.19e-05	0.000355	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MMP2—atherosclerosis	3.15e-05	0.000351	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.13e-05	0.000348	CbGpPWpGaD
Galantamine—BCHE—Metabolism—HMGCR—atherosclerosis	3.09e-05	0.000344	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ABCA1—atherosclerosis	3.09e-05	0.000344	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—INS—atherosclerosis	3e-05	0.000334	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CCL2—atherosclerosis	2.96e-05	0.000329	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—IGF1—atherosclerosis	2.91e-05	0.000323	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MMP2—atherosclerosis	2.81e-05	0.000313	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.79e-05	0.00031	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ABCA1—atherosclerosis	2.76e-05	0.000307	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	2.75e-05	0.000305	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ABCG1—atherosclerosis	2.71e-05	0.000301	CbGpPWpGaD
Galantamine—ACHE—Metabolism—HMOX1—atherosclerosis	2.65e-05	0.000295	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CXCL8—atherosclerosis	2.62e-05	0.000291	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PLTP—atherosclerosis	2.58e-05	0.000287	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—FABP4—atherosclerosis	2.54e-05	0.000283	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—LCAT—atherosclerosis	2.54e-05	0.000283	CbGpPWpGaD
Galantamine—ACHE—Metabolism—APOB—atherosclerosis	2.54e-05	0.000282	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—APOA4—atherosclerosis	2.5e-05	0.000278	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTM1—atherosclerosis	2.47e-05	0.000275	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP7A1—atherosclerosis	2.45e-05	0.000273	CbGpPWpGaD
Galantamine—ACHE—Metabolism—LPL—atherosclerosis	2.42e-05	0.00027	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GPX1—atherosclerosis	2.37e-05	0.000263	CbGpPWpGaD
Galantamine—BCHE—Metabolism—HMOX1—atherosclerosis	2.36e-05	0.000263	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CXCL8—atherosclerosis	2.34e-05	0.00026	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CD36—atherosclerosis	2.3e-05	0.000256	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP27A1—atherosclerosis	2.27e-05	0.000252	CbGpPWpGaD
Galantamine—BCHE—Metabolism—APOB—atherosclerosis	2.26e-05	0.000252	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.24e-05	0.000249	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.24e-05	0.000249	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTM1—atherosclerosis	2.2e-05	0.000245	CbGpPWpGaD
Galantamine—ACHE—Metabolism—MTHFR—atherosclerosis	2.18e-05	0.000243	CbGpPWpGaD
Galantamine—BCHE—Metabolism—LPL—atherosclerosis	2.16e-05	0.000241	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—APOA2—atherosclerosis	2.15e-05	0.000239	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	2.15e-05	0.000239	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	2.15e-05	0.000239	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALOX15—atherosclerosis	2.15e-05	0.000239	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PPARA—atherosclerosis	2.14e-05	0.000238	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ABCG5—atherosclerosis	2.12e-05	0.000236	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GPX1—atherosclerosis	2.11e-05	0.000235	CbGpPWpGaD
Galantamine—ACHE—Metabolism—AGT—atherosclerosis	2.07e-05	0.000231	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CD36—atherosclerosis	2.05e-05	0.000229	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—LPA—atherosclerosis	2.05e-05	0.000228	CbGpPWpGaD
Galantamine—ACHE—Metabolism—APOE—atherosclerosis	2.03e-05	0.000226	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CAV1—atherosclerosis	2.01e-05	0.000224	CbGpPWpGaD
Galantamine—ACHE—Metabolism—APOA1—atherosclerosis	2.01e-05	0.000223	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—BGN—atherosclerosis	1.99e-05	0.000221	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—APOA5—atherosclerosis	1.97e-05	0.000219	CbGpPWpGaD
Galantamine—BCHE—Metabolism—MTHFR—atherosclerosis	1.95e-05	0.000217	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PPARA—atherosclerosis	1.91e-05	0.000212	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.89e-05	0.000211	CbGpPWpGaD
Galantamine—BCHE—Metabolism—AGT—atherosclerosis	1.85e-05	0.000206	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CG—atherosclerosis	1.83e-05	0.000204	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.83e-05	0.000203	CbGpPWpGaD
Galantamine—BCHE—Metabolism—APOE—atherosclerosis	1.81e-05	0.000202	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CAV1—atherosclerosis	1.8e-05	0.0002	CbGpPWpGaD
Galantamine—BCHE—Metabolism—APOA1—atherosclerosis	1.79e-05	0.000199	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PPARG—atherosclerosis	1.77e-05	0.000197	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.77e-05	0.000197	CbGpPWpGaD
Galantamine—ACHE—Metabolism—INS—atherosclerosis	1.74e-05	0.000193	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—FABP4—atherosclerosis	1.66e-05	0.000185	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—LCAT—atherosclerosis	1.66e-05	0.000185	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.64e-05	0.000182	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CG—atherosclerosis	1.64e-05	0.000182	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—APOA4—atherosclerosis	1.63e-05	0.000182	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—LIPC—atherosclerosis	1.63e-05	0.000181	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—APOC3—atherosclerosis	1.62e-05	0.00018	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—LDLR—atherosclerosis	1.61e-05	0.000179	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.6e-05	0.000178	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ALB—atherosclerosis	1.59e-05	0.000177	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PPARG—atherosclerosis	1.58e-05	0.000176	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CETP—atherosclerosis	1.57e-05	0.000175	CbGpPWpGaD
Galantamine—BCHE—Metabolism—INS—atherosclerosis	1.55e-05	0.000172	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NOS3—atherosclerosis	1.52e-05	0.000169	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.51e-05	0.000167	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.48e-05	0.000165	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.42e-05	0.000158	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ALB—atherosclerosis	1.42e-05	0.000158	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.41e-05	0.000156	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—APOA2—atherosclerosis	1.41e-05	0.000156	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.41e-05	0.000156	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.41e-05	0.000156	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTGS2—atherosclerosis	1.39e-05	0.000155	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.39e-05	0.000154	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NOS3—atherosclerosis	1.36e-05	0.000151	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—LPA—atherosclerosis	1.34e-05	0.000149	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—BGN—atherosclerosis	1.3e-05	0.000144	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—APOA5—atherosclerosis	1.29e-05	0.000143	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.27e-05	0.000141	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTGS2—atherosclerosis	1.24e-05	0.000138	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.24e-05	0.000138	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.2e-05	0.000133	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.09e-05	0.000121	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.07e-05	0.000119	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—LIPC—atherosclerosis	1.07e-05	0.000118	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—APOC3—atherosclerosis	1.06e-05	0.000118	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—LDLR—atherosclerosis	1.05e-05	0.000117	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—APOB—atherosclerosis	1.04e-05	0.000116	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CETP—atherosclerosis	1.03e-05	0.000114	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.01e-05	0.000113	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—LPL—atherosclerosis	9.94e-06	0.000111	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SCARB1—atherosclerosis	9.84e-06	0.000109	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GPX1—atherosclerosis	9.7e-06	0.000108	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CD36—atherosclerosis	9.45e-06	0.000105	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HMGCR—atherosclerosis	9.3e-06	0.000103	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—MTHFR—atherosclerosis	8.95e-06	9.96e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PPARA—atherosclerosis	8.78e-06	9.77e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—AGT—atherosclerosis	8.51e-06	9.46e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—APOE—atherosclerosis	8.33e-06	9.27e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ABCA1—atherosclerosis	8.28e-06	9.21e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CAV1—atherosclerosis	8.26e-06	9.19e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—APOA1—atherosclerosis	8.24e-06	9.16e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	7.52e-06	8.37e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PPARG—atherosclerosis	7.26e-06	8.07e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—INS—atherosclerosis	7.12e-06	7.92e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—HMOX1—atherosclerosis	7.11e-06	7.91e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—AKT1—atherosclerosis	7e-06	7.78e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—APOB—atherosclerosis	6.81e-06	7.57e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTM1—atherosclerosis	6.62e-06	7.37e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ALB—atherosclerosis	6.53e-06	7.26e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—LPL—atherosclerosis	6.5e-06	7.23e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GPX1—atherosclerosis	6.34e-06	7.05e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NOS3—atherosclerosis	6.24e-06	6.95e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—AKT1—atherosclerosis	6.24e-06	6.94e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CD36—atherosclerosis	6.18e-06	6.87e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—MTHFR—atherosclerosis	5.85e-06	6.51e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PPARA—atherosclerosis	5.74e-06	6.39e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTGS2—atherosclerosis	5.71e-06	6.35e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—AGT—atherosclerosis	5.56e-06	6.19e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—APOE—atherosclerosis	5.45e-06	6.06e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CAV1—atherosclerosis	5.4e-06	6.01e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—APOA1—atherosclerosis	5.39e-06	5.99e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.92e-06	5.47e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PPARG—atherosclerosis	4.75e-06	5.28e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—INS—atherosclerosis	4.66e-06	5.18e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ALB—atherosclerosis	4.27e-06	4.75e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NOS3—atherosclerosis	4.08e-06	4.54e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.73e-06	4.15e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—AKT1—atherosclerosis	2.87e-06	3.19e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—AKT1—atherosclerosis	1.88e-06	2.09e-05	CbGpPWpGaD
